NTPC Share Price: What does CLSA say about Zidas Life, NPTC, Shree Cement and more?

NEW DELHI: Global brokerage firm CLSA has shared its views on a number of stocks in various sectors, including cement, pharma, power and steel. Brokers have mixed views on these counters.

CLSA maintains a buy rating

With a target price of Rs 180, thanks to market growth. “NPTC is leading a change of power,” it added The broker said NPTC ended FY22 on a good note with a 43 percent increase in renewable capacity.

On

CLSA has a counter rating with a target price of Rs 490 as it sees a favorable risk reward ratio with a limited negative aspect.



“Expenditure optimization offsets inflationary pressures,” said a global broker. “The underlying growth is very strong in India, where US business is down 5 percent on a hierarchical basis.”

On the contrary, it has a neutral rating

With a target price of Rs 22,600. “The company’s revenue / EBITDA expectations were lower than in the March 2022 quarter,” it added. Rising spending will also hurt profitability.

The CLSA has lowered its estimates on steel reserves after the finance ministry announced export tariffs on steel products. “Lower coking coal and iron ore are the main concerns with domestic steel prices that are likely to be corrected,” it added.

It downgraded the three main steel counters – (Purchase to Underperform), (Purchase to Perform) and (Purchase to Perform).


(Disclaimer: The recommendations, suggestions, opinions and opinions offered by the experts are their own. These do not represent the views of the Economic Times)

Related Posts

Leave a Reply

Your email address will not be published.